← Evidence library

BIB_056

Long GV, Hauschild A, Santinami M, et al. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. NEJM 2017;377:1813–1823. COMBI-AD. [Tasks: L, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade

A

Tier

2

Cited by tasks

L, 18

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_056/findings.md (research corpus). This page is a short context summary — not individualised medical advice.